MedTrace Logo

LiquID Guide Catheter Extension Safety Study

NCT05406596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2024-05-23

Study results available
· View outcomes & findings →

Summary

Single arm, open label, historically controlled, multicenter study evaluating the primary safety and performance of the LiquID Guide Catheter Extension

Conditions

Interventions

DEVICE

LiquID GCE Use

Use of the LiquID GCE to aid in percutaneous coronary intervention (PCI)

Sponsors & Collaborators

  • Seigla Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Peter Henriksen, BSc, MB ChB, PhD, FRCP · Royal Edinburgh

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-13
Primary Completion
2023-10-12
Completion
2023-10-20
FDA Device
Yes

Countries

  • Belgium
  • Ireland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05406596 on ClinicalTrials.gov